EP3727339A1 — Pharmaceutical composition containing resin particles
Assigned to DDP Specialty Electronic Materials US LLC · Expires 2020-10-28 · 6y expired
What this patent protects
Provided is a pharmaceutical composition comprising a collection of particles, wherein the particles comprise a drug and an ion exchange resin, wherein 90% or more by weight of the particles pass through a mesh screen having openings of 150μιτι, and wherein 90% or more by weight …
USPTO Abstract
Provided is a pharmaceutical composition comprising a collection of particles, wherein the particles comprise a drug and an ion exchange resin, wherein 90% or more by weight of the particles pass through a mesh screen having openings of 150μιτι, and wherein 90% or more by weight of the particles are retained on a mesh screen having openings of 106μιτι.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.